NEO sarms YK-11

Classification: Selective Androgen Receptor Modulator (SARM)
Structure Steroidal
Standard Synthetic Steroidal ligand
Estrogenic Activity None
Progestational Activity None
Water Retention: None
Aromatization: None
Hepatotoxicity Mild
Active Half-life: 6-12 hours
Recommended Dosage: 5-15 mg/day

SARMs General Info

SARMs are compounds with high anabolic activity (muscle growth) and almost zero androgenic activity.SARMs were designed to replicate the benefits of AAS without prevalent steroids side effects, such as hair loss, acne, prostate hypertrophy in men.SARMs are also very popular among female athletes, mainly because virilization or masculinization is not a concern compared to AAS.
SARMs have become a trendy alternative to AAS in various sports communities.

YK-11 General Info

YK-11 is a steroidal SARM. YK-11 became famous because of its properties as a myostatin inhibitor. Myostatin is a protein responsible for limiting muscle growth, so they do not see change
indefinitely. Currently, YK-11 is not available as a prescription drug. Please note that the manufacturing cost of high-quality SARMs is high. We strongly recommend getting YK-11 only from a reliable source.

YK-11 in Sports

YK-11 is used for physique and performance purposes. YK-11 shows a similar anabolic effect as lean muscle building AAS.YK-11 significantly increases strength and lean muscle mass.YK-11 is considered the most potent SARM for these purposes. No wonder why more and more athletes are turning their heads in the SARMs direction. As we can see, Andarine provides the most critical AAS benefits without a negative impact on the prostate and minimal HTPA inhibition.

YK-11 Main Benefits

Lean Muscle gains
Strength increase
Myostatin Inhibitor
Longer workouts
Shorter rest periods in between sets
Improvement in explosive exercises

YK-11 Administration Men

Recommended dosage range 5-10 mg/day
Recommended cycle length 4-8 weeks

YK-11 Administration Women

Recommended dosage range 1-5 mg/day
Recommended cycle length 4-8 weeks

Administration General

We strongly recommend tapering up the dosage until a comfortable dosage level is achieved. Please start with the minimum recommended dosage (5 mg/day Men and 1mg/day for Women) and increase the dosage by +2mg/day Men and by +1mg/day for Women every seven days.

YK-11 Only Cycle
Primary Goal: Bulking
Level: Beginner
1 Week 2 mg/day
2 Week 4 mg/day
3 Week 6 mg/day
4 Week 8 mg/day
5 Week 10 mg/day
6 Week 10 mg/day
7 Week 10 mg/day
8 Week 10 mg/day

YK-11 Only Cycle
Primary Goal: Bulking
Level: Advanced
1 Week 5 mg/day
2 Week 10 mg/day
3 Week 15 mg/day
4 Week 15 mg/day
5 Week 15 mg/day
6 Week 15 mg/day
7 Week 15 mg/day
8 Week 15 mg/day

YK-11 and Andarine and Cardarine Cycle
Primary Goal: Cutting and Lean Body Mass Increase
1 Week Andarine 25 mg/day Cardarine 20 mg/day YK-11 -5mg/day
2 Week Andarine 35 mg/day Cardarine 20 mg/day YK-11 -5mg/day
3 Week Andarine 45 mg/day Cardarine 20 mg/day YK-11 -5mg/day
4 Week Andarine 45 mg/day Cardarine 20 mg/day YK-11 -5mg/day
5 Week Andarine 45 mg/day Cardarine 20 mg/day YK-11 -5mg/day
6 Week Andarine 45 mg/day Cardarine 20 mg/day YK-11 -5mg/day
7 Week Andarine 45 mg/day Cardarine 20 mg/day YK-11 -5mg/day
8 Week Andarine 45 mg/day Cardarine 20 mg/day YK-11 -5mg/day

Possible Side Effects

YK-11 is considered a well-tolerated SARM. Less than 10% of users reported such side effects as dry mouth and short-term headaches. Once a comfortable dosage level is established, most of these side effects could be avoided.

Natural Testosterone Suppression
YK-11 taken in doses to promote muscle gains is very suppressive of total and free testosterone. It has a strong influence on the HTPA axis as well. Proper use and PCT are highly recommended.

Post Cycle Therapy

The biggest and most dangerous myth about SARMs is that they do not suppress endogenous testosterone production, so Post Cycle Therapy (PCT) is unnecessary after SARM s cycles.
Please note that ANY substance that activates any receptors (androgen, progesterone, or estrogen) will cause to some extent a reduction in the endogenous production of sex hormones. Some compounds have a lesser effect, and some are powerful suppressants.
YK-11 is a steroidal SARM with a high HPTA suppression.

Effective PCT after YK-11 Cycle
1 Week 10 mg/day Nolvadex
2 Week 10 mg/day Nolvadex
3 Week 10 mg/day Nolvadex
4 Week 10 mg/day Nolvadex
5 Week 10 mg/day Nolvadex
6 Week 10 mg/day Nolvadex